John Fogarty

1.1k total citations
10 papers, 856 citations indexed

About

John Fogarty is a scholar working on Clinical Biochemistry, Endocrinology, Diabetes and Metabolism and Urology. According to data from OpenAlex, John Fogarty has authored 10 papers receiving a total of 856 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Clinical Biochemistry, 4 papers in Endocrinology, Diabetes and Metabolism and 3 papers in Urology. Recurrent topics in John Fogarty's work include Advanced Glycation End Products research (6 papers), Urinary Bladder and Prostate Research (3 papers) and Sexual function and dysfunction studies (2 papers). John Fogarty is often cited by papers focused on Advanced Glycation End Products research (6 papers), Urinary Bladder and Prostate Research (3 papers) and Sexual function and dysfunction studies (2 papers). John Fogarty collaborates with scholars based in United States, Sweden and Taiwan. John Fogarty's co-authors include Vincent M. Monnier, David R. Sell, Patrizio Odetti, Annunziata Lapolla, Ramanakoppa H. Nagaraj, Nehemia Hampel, James A. Schulak, Donald E. Hricik, Nosratola D. Vaziri and Kelly Ferguson and has published in prestigious journals such as The Science of The Total Environment, Diabetes and Kidney International.

In The Last Decade

John Fogarty

10 papers receiving 827 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John Fogarty United States 10 497 406 170 147 103 10 856
Medardo Hernández Spain 13 24 0.0× 137 0.3× 102 0.6× 193 1.3× 146 1.4× 22 581
Bilgin Özmen Türkiye 15 68 0.1× 253 0.6× 24 0.1× 95 0.6× 134 1.3× 32 727
D. Morgan Brazil 6 101 0.2× 301 0.7× 20 0.1× 280 1.9× 341 3.3× 8 990
Eduardo Rebelato Brazil 10 107 0.2× 306 0.8× 19 0.1× 281 1.9× 380 3.7× 13 1.1k
Ian Luttrell United States 11 25 0.1× 139 0.3× 104 0.6× 259 1.8× 204 2.0× 16 794
Delminda Neves Portugal 15 27 0.1× 191 0.5× 100 0.6× 143 1.0× 121 1.2× 57 555
Zhezhu Gao China 17 26 0.1× 170 0.4× 186 1.1× 42 0.3× 134 1.3× 20 592
Justin D. La Favor United States 12 23 0.0× 134 0.3× 69 0.4× 165 1.1× 160 1.6× 23 578
Mariana G. de Oliveira Brazil 15 68 0.1× 59 0.1× 25 0.1× 102 0.7× 89 0.9× 46 449
Jürgen Bohlender Germany 20 224 0.5× 508 1.3× 5 0.0× 128 0.9× 366 3.6× 41 1.3k

Countries citing papers authored by John Fogarty

Since Specialization
Citations

This map shows the geographic impact of John Fogarty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Fogarty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Fogarty more than expected).

Fields of papers citing papers by John Fogarty

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Fogarty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Fogarty. The network helps show where John Fogarty may publish in the future.

Co-authorship network of co-authors of John Fogarty

This figure shows the co-authorship network connecting the top 25 collaborators of John Fogarty. A scholar is included among the top collaborators of John Fogarty based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Fogarty. John Fogarty is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Frank, Adrian, David R. Sell, Rolf Danielsson, John Fogarty, & Vincent M. Monnier. (2000). A syndrome of molybdenosis, copper deficiency, and type 2 diabetes in the moose population of south-west Sweden. The Science of The Total Environment. 249(1-3). 123–131. 19 indexed citations
2.
Seftel, Allen D., Nosratola D. Vaziri, John Fogarty, et al.. (1997). Advanced glycation end products in human penis: elevation in diabetic tissue, site of deposition, and possible effect through inos or enos. Urology. 50(6). 1016–1026. 162 indexed citations
3.
Nagaraj, Ramanakoppa H., Timothy S. Kern, David R. Sell, et al.. (1996). Evidence of a Glycemic Threshold for the Formation of Pentosidine in Diabetic Dog Lens but Not in Collagen. Diabetes. 45(5). 587–594. 26 indexed citations
4.
Seftel, A D, et al.. (1995). Age-related increase in an advanced glycation end product in penile tissue. World Journal of Urology. 13(6). 50 indexed citations
5.
Fogarty, John, Charles C. Engel, Joan Russo, Greg Simon, & Wayne Katon. (1994). Hypertension and Pheochromocytoma Testing. Archives of Family Medicine. 3(1). 55–60. 13 indexed citations
6.
Hricik, Donald E., James A. Schulak, David R. Sell, John Fogarty, & Vincent M. Monnier. (1993). Effects of kidney or kidney-pancreas transplantation on plasma pentosidine. Kidney International. 43(2). 398–403. 82 indexed citations
7.
Sell, David R., et al.. (1992). Pentosidine formation in skin correlates with severity of complications in individuals with long-standing IDDM. Diabetes. 41(10). 1286–1292. 71 indexed citations
8.
Odetti, Patrizio, et al.. (1992). Chromatographic quantitation of plasma and erythrocyte pentosidine in diabetic and uremic subjects. Diabetes. 41(2). 153–159. 42 indexed citations
9.
Sell, David R., Annunziata Lapolla, Patrizio Odetti, John Fogarty, & Vincent M. Monnier. (1992). Pentosidine Formation in Skin Correlates With Severity of Complications in Individuals With Long-Standing IDDM. Diabetes. 41(10). 1286–1292. 246 indexed citations
10.
Sell, David R., Ramanakoppa H. Nagaraj, Patrizio Odetti, et al.. (1991). Pentosidine: A molecular marker for the cumulative damage to proteins in diabetes, aging, and uremia. Diabetes/Metabolism Reviews. 7(4). 239–251. 145 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026